Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
01/1991
01/08/1991US4983626 Anti-rheumatic agents and their use
01/08/1991US4983605 Antitumor benzoylureas; nonionic surfactant as dispersant; cellulose, silicic anhydride, sucrose fatty acid ester and/or polyoxyethylene polyoxypropylene glycol as disintegrator
01/08/1991US4983593 Vasodilators, hypotensive agents
01/08/1991US4983583 Granulated compositions of polysaccharides, process for their preparation and use
01/08/1991US4983401 Sustained release pharmaceutical preparations having pH controlled membrane coatings
01/08/1991US4983399 Cellulose ester and lubricant
01/08/1991US4983398 Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
01/08/1991US4983396 Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
01/08/1991US4983394 Flavor enhancing and medicinal taste masking agent
01/08/1991US4983388 Process of preparing silicone composition, and cosmetic and lustering materials containing silicone composition obtained
01/08/1991US4983386 Adding amino acids to aqueous acrylic polymer solution, controlling ph; radiation resistance
01/08/1991US4983385 For wet body surface, water-soluble polymer hydrogel, methacrylate copolymer, solubilizer
01/08/1991CA2062970A1 Benzophenanthridine alkaloids for topical acne treatment
01/08/1991CA2035893A1 Stable preparation containing motilins
01/08/1991CA2035892A1 Aqueous solution containing motilins
01/08/1991CA2020654A1 Stabilized fgf composition and production thereof
01/07/1991WO1991001004A1 Hybrid molecules
01/07/1991CA2035868A1 Hybrid molecules
01/06/1991CA2019086A1 Modified pf4 compositions and methods of use
01/05/1991WO1991000280A1 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones and the corresponding hydroxy acids
01/05/1991CA2060212A1 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2h- pyran-2-ones and the corresponding hydroxy acids
01/02/1991EP0406015A1 Intermittent release dosage form
01/02/1991EP0405930A2 Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
01/02/1991EP0405299A2 Composition for the treatment of acute herpetic neuralgia and post-herpetic neuralgia
01/02/1991CN1048220A Polystyrenesulfonate
01/02/1991CA1278521C Composition for personal care product comprising alkoxylated fatty alcohol and polysiloxane
01/01/1991US4981979 Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
01/01/1991US4981953 Antitumor
01/01/1991US4981902 Drug delivery
01/01/1991US4981852 Hypotensive, diuretic, liquids
01/01/1991US4981695 Composition comprising L-dopa
01/01/1991US4981694 Penicillin preparation for rectal administration
01/01/1991US4981693 Pharmaceutical composition for periodontal diseases
01/01/1991US4981684 Formation of adjuvant complexes
01/01/1991US4981681 Lotion mixture and method of treating psoriasis
01/01/1991US4981678 Foamable biocide composition
12/1990
12/27/1990WO1990015807A1 Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
12/27/1990WO1990015628A1 Polymer/antibiotic conjugate
12/27/1990WO1990015627A1 Methods and compositions for the preparation and use of site-directed immunologic reagents
12/27/1990WO1990015614A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA
12/27/1990EP0404747A1 Novel polystyrenesulfonate
12/27/1990EP0404640A1 5,6,7,8-Tetrahydro-1-naphtalenol derivatives, process for their preparation and their use as antioxidants in cosmetic and pharmaceutical compositions
12/27/1990EP0404558A1 Liquid polymer composition, and method of use
12/27/1990EP0404490A1 Fast dissolving dosage forms
12/27/1990EP0404376A2 Buffered metronidazole compositions for intravaginal treatment of vaginal infections
12/27/1990EP0403961A2 Magnetic protein conjugates, process to make them and their use
12/27/1990EP0403959A1 Film forming aqueous coating preparation for solid pharmaceuticals, its production and use
12/27/1990EP0403748A2 Oral lipid medicinal form
12/27/1990EP0403605A1 Elastase inhibiting polymers and methods
12/27/1990EP0348507A4 Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis
12/27/1990EP0311632A4 Surface active lactams
12/27/1990EP0229108B1 Solubilization of proteins for pharmaceutical compositions using polymer conjugation
12/27/1990EP0214995B1 Immunotoxin and method of making
12/27/1990CA2019724A1 Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
12/25/1990US4980457 Coupling of ricin and antibody
12/25/1990US4980378 Increase penetration of drugs
12/25/1990US4980175 Liquid orally administrable compositions based on edible oils
12/25/1990US4980171 Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative
12/25/1990US4980169 Using capsicum oleoresin
12/25/1990US4980165 Pharmaceutical formulations of plasminogen activator proteins
12/21/1990WO1990015793A1 Novel polystyrenesulfonate
12/21/1990WO1990015792A1 Novel cyclodextrin inclusion complexes
12/21/1990CA2059282A1 Polystyrenesulfonate
12/21/1990CA2058996A1 Cyclodextrin inclusion complexes
12/20/1990CA2019228A1 Fast dissolving dosage forms
12/19/1990EP0403400A1 Functionalized silicon oil-based aqueous dispersion cross-linking to an elastomer by elimination of water
12/19/1990EP0403395A1 Process for the one-step preparation of cross-linked poly beta-alanine from acrylamide and a polyfunctional compound copolymerisable therewith
12/19/1990EP0403383A1 Sustained release pharmaceutical formulations
12/19/1990EP0403156A1 Improved monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
12/19/1990EP0403048A2 Medicated compositions containing sucralfate and processes for their production
12/19/1990EP0402933A2 Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics
12/19/1990EP0402805A1 Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin
12/19/1990EP0402418A1 Physiological active liquid allergenic composition from biological raw materials
12/19/1990EP0402369A1 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone
12/19/1990EP0211023B1 Pharmaceutical composition containing ubidecarenone
12/19/1990CN1047803A Etoposide preparations
12/19/1990CN1047802A Moisturing vehicle for topical application of vitamin a acid
12/18/1990US4978772 Utilization of otilonium bromide (DCI) for topical application in the gastroinstestinal tract and related pharmaceutical formulation appropriate for such use
12/18/1990US4978534 Viscosity controlling agent
12/18/1990US4978532 Dosage form for administration of dehydroepiandrosterone
12/18/1990US4978527 Aqueous mixture with iodine-containing copolymers forms hydrophobic wear resistant film on skin; drug delivery
12/18/1990US4978516 Process for treating talc
12/18/1990CA1277910C Color stabilized hydrogel dressing and process
12/16/1990WO1990015596A1 Glucan drug delivery system and adjuvant
12/16/1990CA2059275A1 Glucan drug delivery system and adjuvant
12/16/1990CA2019108A1 Sustained release pharmaceutical formulations
12/15/1990WO1990015619A1 FACTOR Xa BASED ANTICOAGULANT COMPOSITIONS
12/15/1990CA2019012A1 Process for the preparation of cross-linked poly-.beta.-alanine in one step from acrylamide and a copolymerisable polyfunctional compound
12/14/1990WO1991008734A1 Anhydrous oil-based liquid suspension for delivering a medicament
12/14/1990CA2060501A1 Anhydrous oil-based liquid suspension for delivering a medicament
12/14/1990CA2018945A1 Sucralfate and a medicament and methods for preparing same
12/14/1990CA2018833A1 Polymer/antibiotic conjugate
12/13/1990WO1990015141A2 Self-assembled, defective, non-self-propagating viral particles
12/13/1990WO1990015077A1 Monoclonal antibody specific for bacterial transport proteins, and antibody-containing deodorant composition
12/13/1990WO1990014881A2 Chelating agents for attaching metal ions to proteins
12/13/1990WO1990014844A2 Sugars as cleavable linkers for the delivery and release of agents in native form
12/13/1990WO1990014837A1 Adjuvant formulation comprising a submicron oil droplet emulsion
12/13/1990WO1990014834A1 Pvp-hi-i2 complexes having a partition coefficient above 300, and process for making same
12/13/1990WO1990014832A1 Improved intravaginal treatment of vaginal infections with buffered metronidazole compositions
12/13/1990WO1990014819A1 An ointment